• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Female Viagra and a Fed update–5 things to know today

By
Laura Lorenzetti
Laura Lorenzetti
and
Geoffrey Smith
Geoffrey Smith
Down Arrow Button Icon
By
Laura Lorenzetti
Laura Lorenzetti
and
Geoffrey Smith
Geoffrey Smith
Down Arrow Button Icon
August 19, 2015, 6:21 AM ET

Hello friends and Fortune readers.

Wall Street stock futures are lower again this morning after another volatile session in China did nothing to ease fears over the strength of the global economy. Crude oil futures are down a little at just below $43, but are still nearly $1/barrel off their recent lows.

Today’s must-read story is by Fortune’s Chris Matthews on why young Americans are putting off buying their first homes. Hint: it’s not because they don’t have the money. Read more here.

Here’s what else you need to know today.

1. FDA finally approves the “Female Viagra”

The Food and Drug Administration has approved (at the third time of asking) the use of Sprout Pharmaceuticals Inc.’s Flibanserin, a new drug that boosts women’s libido and has been termed ‘the female Viagra’. The drug was trialed clinically on over 11,000 women over a 24-week period, and was found to be an effective remedy to “hypoactive sexual desire disorder,” or HSDD), a condition suffered mainly by pre-menopausal women.

 

2. How close is the Fed to raising interest rates?

That’s the question on everyone’s minds ahead of the Federal Reserve’s release of its minutes from its July policy-setting session. A rate hike may well be on the horizon for September–at least 82% of economists seem to feel that way. Changes to its July statement pointed in the direction of a September hike, and investors will be parsing the minutes carefully for further indication that the Fed feels the U.S. economy is getting closer to its targets.

3. Target is aiming for the sweet spot.

Target (TGT) reports its second-quarter earnings before the market open today, and given updates from other retailers, things aren’t looking rosy. There’s been some high-level departures at the retailer in recent weeks, and new CEO Brian Cornell has only been at the helm since last August. The company’s been busy restructuring operations and focusing on fewer products, including baby, kids and wellness products, which it hopes will help boost sales. Earnings per share are expected to be up slightly year-over-year to $1.11.

[fortune-brightcove videoid=4073047667001]

 

4. Lowe’s struggles to play catchup.

Lowe’s Companies (LOW) reports its second-quarter earnings a day after No. 1 rival Home Depot (HD), which raised its 2015 profit outlook for the second time this year. Lowe’s doesn’t seem to be catching the same home improvement bump and is likely to report sales below the average analyst estimate. It also had a rough first quarter with weaker-than-expected sales. Analysts will be listening carefully for a full-year update.

5. American Eagle rides the teen wave.

Teen retailer American Eagle Outfitters (AEO) reports second-quarter earnings today, and analysts expect the company to surpass expectations. A potential earnings beat would be a credit to American Eagle’s on-trend merchandise, lower discounts and tight inventory controls. The company’s been able to efficiently implement an omnichannel strategy that more efficiently moves products between its brick-and-mortar and online stock. Investors will also be anxious to get a sneak peak into this year’s back-to-school shopping season.

Additional reporting contributed by Reuters.

About the Authors
By Laura Lorenzetti
See full bioRight Arrow Button Icon
By Geoffrey Smith
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

hybrid
Future of Workhybrid
‘Hybrid creep’ is the latest trick bosses are using to get workers back in the office
By Nick LichtenbergJanuary 13, 2026
2 hours ago
Successthe future of work
Robot surgeons in 3 years, longer lifespans, and no need for retirement savings: Elon Musk shares 4 bold predictions for the future of work
By Orianna Rosa RoyleJanuary 13, 2026
3 hours ago
Healthexercise
5 daily tasks that can double as exercise
By Molly Liebergall and Morning BrewJanuary 12, 2026
20 hours ago
A smartphone displaying the app icon for Anthropic AI chatbot Claude displayed against a backdrop that also says "Claude."
AIAnthropic
Anthropic unveils Claude for Healthcare, expands life science features, and partners with HealthEx to let users connect medical records
By Jeremy KahnJanuary 11, 2026
2 days ago
Elon Musk, wearing a suit, puts his knuckles together and looks upward.
TechElon Musk
Elon Musk asked people to upload their medical data to X so his AI company could learn to interpret MRIs and CT scans
By Sasha RogelbergJanuary 11, 2026
2 days ago
SuccessLongevity
CEO coach to the Fortune 500: The most powerful way to tackle 2026 is assuming you’ll live till 130
By Bill HoogterpJanuary 10, 2026
3 days ago

Most Popular

placeholder alt text
Economy
Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30 billion from a year prior
By Eleanor PringleJanuary 12, 2026
1 day ago
placeholder alt text
Economy
‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
By Jim EdwardsJanuary 12, 2026
1 day ago
placeholder alt text
Newsletters
The oil CEO who stood up to Trump is a follower of the disciplined 'Exxon way' and has a history of blunt statements
By Jordan BlumJanuary 13, 2026
8 hours ago
placeholder alt text
Success
An exec at $62 billion giant Colgate says Gen Z workers, despite getting flak for being woke and lazy, are actually ‘pushing us to get better’
By Emma BurleighJanuary 10, 2026
3 days ago
placeholder alt text
AI
This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he'd do it again
By Nick LichtenbergJanuary 11, 2026
2 days ago
placeholder alt text
Real Estate
'Something big' just happened in the U.S. housing market, real estate CEO says. And it could mean the difference of being able to buy a home or not
By Sydney LakeJanuary 12, 2026
1 day ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.